In a world where personalized medicine is rapidly becoming the cornerstone of effective healthcare, the challenge of accurately diagnosing and treating complex conditions like cancer has never been more pressing, and theranostic imaging stands at the forefront of this transformation. Theranostic
In the rapidly evolving field of nuclear medicine, the phenomenon of non-specific uptake (NSU) of 68Ga-FAPI during positron emission tomography/computed tomography (PET/CT) imaging has emerged as a significant diagnostic challenge, particularly when observed in the pancreas of patients with no
For millions around the globe, the aftermath of a SARS-CoV-2 infection has introduced a lingering challenge known as Long COVID, with brain fog emerging as one of its most debilitating and widespread symptoms, affecting over 80% of those diagnosed with this chronic condition. Brain fog clouds the
The startling decline in the availability of federal data under recent policy shifts is creating a profound crisis for public health initiatives aimed at addressing health disparities across the United States. This critical information, which forms the bedrock for identifying inequities in health
Imagine a world where cancer treatment is as unique as a fingerprint, tailored precisely to the molecular makeup of an individual’s tumor with minimal harm to surrounding healthy tissues, a vision that is no longer a distant dream but a tangible reality thanks to theranostics. This innovative
In the ever-evolving landscape of cancer treatment, UCLA Health Jonsson Comprehensive Cancer Center stands as a beacon of innovation, showcasing remarkable advancements at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Francisco this year. Their leadership in the field is
